Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-?-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.

Source:http://linkedlifedata.com/resource/pubmed/id/20362304

Download in:

View as

General Info

PMID
20362304